The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Personalized Therapy Biosimulation Platform Market 2025 by Company, Regions, Type and Application, Forecast to 2029

Global Personalized Therapy Biosimulation Platform Market 2025 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1754570

No of Pages : 103

Ask Your Query

Synopsis
The global Personalized Therapy Biosimulation Platform market size was valued at USD 1434.7 million in 2022 and is forecast to a readjusted size of USD 3583.9 million by 2029 with a CAGR of 14.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Increasing prevalence of malignancies and cancers, rising demand for biologics and biopharmaceuticals, high failure rate of clinical trials and high incidence of drug resistance are the key factors driving the growth of biomimetic personalized therapy market revenue.

Personalized Therapy Biosimulation refers to biosimulating a patient's unique cancer response to therapy prior to treatment and identifying new drug combinations for refractory patients. By utilizing this technology to determine a patient's Therapeutic Response Index, or TRI. TRIs in treatment-naive patients determine whether a patient will respond to standard-of-care treatments. For relapsed or refractory patients, TRIs identify the ideal combination of FDA-approved drugs that patients will respond to.

This report is a detailed and comprehensive analysis for global Personalized Therapy Biosimulation Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Personalized Therapy Biosimulation Platform market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Personalized Therapy Biosimulation Platform market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Personalized Therapy Biosimulation Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Personalized Therapy Biosimulation Platform market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Personalized Therapy Biosimulation Platform
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Personalized Therapy Biosimulation Platform market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellworks Group, Certara, Simulation Plus, Schrodinger and In Silico Biosciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Personalized Therapy Biosimulation Platform market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Pharmacokinetic
  • Pharmacoeconomics

Market segment by Application

  • Pharmaceutical and Biotech Companies
  • Research Institutions
  • Hospital
  • Others

Market segment by players, this report covers

  • Cellworks Group
  • Certara
  • Simulation Plus
  • Schrodinger
  • In Silico Biosciences
  • Genedata
  • Physiomics
  • Insilico Biotechology
  • Chemical Computing Group ULC(CCG)
  • Evidera
  • AnyLogic
  • Shanghai Lide

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Personalized Therapy Biosimulation Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Therapy Biosimulation Platform, with revenue, gross margin and global market share of Personalized Therapy Biosimulation Platform from 2018 to 2023.
Chapter 3, the Personalized Therapy Biosimulation Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Personalized Therapy Biosimulation Platform market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Therapy Biosimulation Platform.
Chapter 13, to describe Personalized Therapy Biosimulation Platform research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Personalized Therapy Biosimulation Platform
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Therapy Biosimulation Platform by Type
1.3.1 Overview: Global Personalized Therapy Biosimulation Platform Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Personalized Therapy Biosimulation Platform Consumption Value Market Share by Type in 2022
1.3.3 Pharmacokinetic
1.3.4 Pharmacoeconomics
1.4 Global Personalized Therapy Biosimulation Platform Market by Application
1.4.1 Overview: Global Personalized Therapy Biosimulation Platform Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical and Biotech Companies
1.4.3 Research Institutions
1.4.4 Hospital
1.4.5 Others
1.5 Global Personalized Therapy Biosimulation Platform Market Size & Forecast
1.6 Global Personalized Therapy Biosimulation Platform Market Size and Forecast by Region
1.6.1 Global Personalized Therapy Biosimulation Platform Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Personalized Therapy Biosimulation Platform Market Size by Region, (2018-2029)
1.6.3 North America Personalized Therapy Biosimulation Platform Market Size and Prospect (2018-2029)
1.6.4 Europe Personalized Therapy Biosimulation Platform Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size and Prospect (2018-2029)
1.6.6 South America Personalized Therapy Biosimulation Platform Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Personalized Therapy Biosimulation Platform Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Cellworks Group
2.1.1 Cellworks Group Details
2.1.2 Cellworks Group Major Business
2.1.3 Cellworks Group Personalized Therapy Biosimulation Platform Product and Solutions
2.1.4 Cellworks Group Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Cellworks Group Recent Developments and Future Plans
2.2 Certara
2.2.1 Certara Details
2.2.2 Certara Major Business
2.2.3 Certara Personalized Therapy Biosimulation Platform Product and Solutions
2.2.4 Certara Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Certara Recent Developments and Future Plans
2.3 Simulation Plus
2.3.1 Simulation Plus Details
2.3.2 Simulation Plus Major Business
2.3.3 Simulation Plus Personalized Therapy Biosimulation Platform Product and Solutions
2.3.4 Simulation Plus Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Simulation Plus Recent Developments and Future Plans
2.4 Schrodinger
2.4.1 Schrodinger Details
2.4.2 Schrodinger Major Business
2.4.3 Schrodinger Personalized Therapy Biosimulation Platform Product and Solutions
2.4.4 Schrodinger Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Schrodinger Recent Developments and Future Plans
2.5 In Silico Biosciences
2.5.1 In Silico Biosciences Details
2.5.2 In Silico Biosciences Major Business
2.5.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Product and Solutions
2.5.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 In Silico Biosciences Recent Developments and Future Plans
2.6 Genedata
2.6.1 Genedata Details
2.6.2 Genedata Major Business
2.6.3 Genedata Personalized Therapy Biosimulation Platform Product and Solutions
2.6.4 Genedata Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genedata Recent Developments and Future Plans
2.7 Physiomics
2.7.1 Physiomics Details
2.7.2 Physiomics Major Business
2.7.3 Physiomics Personalized Therapy Biosimulation Platform Product and Solutions
2.7.4 Physiomics Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Physiomics Recent Developments and Future Plans
2.8 Insilico Biotechology
2.8.1 Insilico Biotechology Details
2.8.2 Insilico Biotechology Major Business
2.8.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Product and Solutions
2.8.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Insilico Biotechology Recent Developments and Future Plans
2.9 Chemical Computing Group ULC(CCG)
2.9.1 Chemical Computing Group ULC(CCG) Details
2.9.2 Chemical Computing Group ULC(CCG) Major Business
2.9.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product and Solutions
2.9.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Chemical Computing Group ULC(CCG) Recent Developments and Future Plans
2.10 Evidera
2.10.1 Evidera Details
2.10.2 Evidera Major Business
2.10.3 Evidera Personalized Therapy Biosimulation Platform Product and Solutions
2.10.4 Evidera Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Evidera Recent Developments and Future Plans
2.11 AnyLogic
2.11.1 AnyLogic Details
2.11.2 AnyLogic Major Business
2.11.3 AnyLogic Personalized Therapy Biosimulation Platform Product and Solutions
2.11.4 AnyLogic Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AnyLogic Recent Developments and Future Plans
2.12 Shanghai Lide
2.12.1 Shanghai Lide Details
2.12.2 Shanghai Lide Major Business
2.12.3 Shanghai Lide Personalized Therapy Biosimulation Platform Product and Solutions
2.12.4 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Lide Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personalized Therapy Biosimulation Platform Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Personalized Therapy Biosimulation Platform by Company Revenue
3.2.2 Top 3 Personalized Therapy Biosimulation Platform Players Market Share in 2022
3.2.3 Top 6 Personalized Therapy Biosimulation Platform Players Market Share in 2022
3.3 Personalized Therapy Biosimulation Platform Market: Overall Company Footprint Analysis
3.3.1 Personalized Therapy Biosimulation Platform Market: Region Footprint
3.3.2 Personalized Therapy Biosimulation Platform Market: Company Product Type Footprint
3.3.3 Personalized Therapy Biosimulation Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Personalized Therapy Biosimulation Platform Consumption Value and Market Share by Type (2018-2023)
4.2 Global Personalized Therapy Biosimulation Platform Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Personalized Therapy Biosimulation Platform Consumption Value Market Share by Application (2018-2023)
5.2 Global Personalized Therapy Biosimulation Platform Market Forecast by Application (2024-2029)
6 North America
6.1 North America Personalized Therapy Biosimulation Platform Consumption Value by Type (2018-2029)
6.2 North America Personalized Therapy Biosimulation Platform Consumption Value by Application (2018-2029)
6.3 North America Personalized Therapy Biosimulation Platform Market Size by Country
6.3.1 North America Personalized Therapy Biosimulation Platform Consumption Value by Country (2018-2029)
6.3.2 United States Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
6.3.3 Canada Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
6.3.4 Mexico Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Personalized Therapy Biosimulation Platform Consumption Value by Type (2018-2029)
7.2 Europe Personalized Therapy Biosimulation Platform Consumption Value by Application (2018-2029)
7.3 Europe Personalized Therapy Biosimulation Platform Market Size by Country
7.3.1 Europe Personalized Therapy Biosimulation Platform Consumption Value by Country (2018-2029)
7.3.2 Germany Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
7.3.3 France Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
7.3.5 Russia Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
7.3.6 Italy Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Personalized Therapy Biosimulation Platform Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Personalized Therapy Biosimulation Platform Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region
8.3.1 Asia-Pacific Personalized Therapy Biosimulation Platform Consumption Value by Region (2018-2029)
8.3.2 China Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
8.3.3 Japan Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
8.3.4 South Korea Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
8.3.5 India Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
8.3.7 Australia Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
9 South America
9.1 South America Personalized Therapy Biosimulation Platform Consumption Value by Type (2018-2029)
9.2 South America Personalized Therapy Biosimulation Platform Consumption Value by Application (2018-2029)
9.3 South America Personalized Therapy Biosimulation Platform Market Size by Country
9.3.1 South America Personalized Therapy Biosimulation Platform Consumption Value by Country (2018-2029)
9.3.2 Brazil Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
9.3.3 Argentina Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Personalized Therapy Biosimulation Platform Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Personalized Therapy Biosimulation Platform Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country
10.3.1 Middle East & Africa Personalized Therapy Biosimulation Platform Consumption Value by Country (2018-2029)
10.3.2 Turkey Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
10.3.4 UAE Personalized Therapy Biosimulation Platform Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Personalized Therapy Biosimulation Platform Market Drivers
11.2 Personalized Therapy Biosimulation Platform Market Restraints
11.3 Personalized Therapy Biosimulation Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Personalized Therapy Biosimulation Platform Industry Chain
12.2 Personalized Therapy Biosimulation Platform Upstream Analysis
12.3 Personalized Therapy Biosimulation Platform Midstream Analysis
12.4 Personalized Therapy Biosimulation Platform Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock